Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by nowayouton Mar 21, 2006 1:20pm
277 Views
Post# 10539901

RE: Short term players are selling

RE: Short term players are sellingRe: price target.I think you may have interpreted $6 by 2010 wrong. "In arriving at our $6 price target, we apply a 30x multiple to our 2010 EPS estimate of USD .40, discounted annually at 25%". I take this to mean a price target in 2010 of .40x 30= $12 USD. Discounted at 25% per year would equal to a 1 year price target of $6 USD.This would assume a successful European trial, and possibly partnership.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities